Statistics for Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: Experience in Turkey
Total visits
views | |
---|---|
Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: Experience in Turkey | 0 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
File Visits
views | |
---|---|
Özkocaman_vd_2015.pdf | 7 |